drug protocol number

CT17/016/R

drug sponsor

KAIMRC

drug study

• BUSULFAN• FLUDARABINE PHOSPHATE• ETOPOSIDE

drug trial site

King Abdulaziz Medical City NG (Riyadh)

drug status

Completed

drug phase